Global Healthcare Private Equity Report 2026
Record highs, renewed momentum, ready for more
Healthcare private equity reached a record high in global deal value in 2025, powered by large transactions and overcoming a slowdown in the second quarter in both North America and Asia-Pacific. Deal count posted the second-highest annual total on record, with strength across all deal sizes. And provider and biopharma anchored activity while healthcare IT continued to grow its share of healthcare transaction volume.
Our report explores the underlying trends in 2025, including rising investor confidence in market fundamentals in the face of headwinds, the importance of operational sophistication, the return of sponsor-to-sponsor activity, and the growing importance of AI and technology. Looking ahead, investors will need conviction in their value-creation playbooks to deliver outsized returns as competition for assets remains intense.
— Bain’s Healthcare Private Equity Leadership Team
Healthcare private equity reached a record high in global deal value in 2025, powered by large transactions and overcoming a slowdown in the second quarter in both North America and Asia-Pacific. Deal count posted the second-highest annual total on record, with strength across all deal sizes. And provider and biopharma anchored activity while healthcare IT continued to grow its share of healthcare transaction volume.
Our report explores the underlying trends in 2025, including rising investor confidence in market fundamentals in the face of headwinds, the importance of operational sophistication, the return of sponsor-to-sponsor activity, and the growing importance of AI and technology. Looking ahead, investors will need conviction in their value-creation playbooks to deliver outsized returns as competition for assets remains intense.
— Bain’s Healthcare Private Equity Leadership Team
